NKTR vs. PGY
NKTR (Nektar Therapeutics) and PGY (Pagaya Technologies Ltd.) are both stocks. NKTR operates in Biotechnology (Healthcare), while PGY operates in Software - Infrastructure (Technology). Over the past 3 years, NKTR returned 84.73%/yr vs 2.59%/yr for PGY. At a 0.25 correlation, their price movements are largely independent.
Performance
NKTR vs. PGY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NKTR achieves a 38.51% return, which is significantly higher than PGY's -26.84% return.
NKTR
- 1D
- -8.30%
- 1M
- -32.27%
- YTD
- 38.51%
- 6M
- 6.76%
- 1Y
- 390.21%
- 3Y*
- 84.73%
- 5Y*
- -26.23%
- 10Y*
- -13.07%
PGY
- 1D
- -2.24%
- 1M
- 7.37%
- YTD
- -26.84%
- 6M
- -34.15%
- 1Y
- -8.55%
- 3Y*
- 2.59%
- 5Y*
- —
- 10Y*
- —
NKTR vs. PGY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
NKTR Nektar Therapeutics | 38.51% | 203.08% | 64.60% | -75.00% | -45.67% |
PGY Pagaya Technologies Ltd. | -26.84% | 124.97% | -43.90% | 11.29% | -79.61% |
Correlation
The correlation between NKTR and PGY is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Jun 24, 2022 | 0.25 |
Fundamentals
NKTR:
$1.45B
PGY:
$1.48B
NKTR:
-$8.64
PGY:
$1.06
NKTR:
19.26
PGY:
1.09
NKTR:
2.51
PGY:
2.79
NKTR:
$55.63M
PGY:
$1.30B
NKTR:
$44.58M
PGY:
$396.55M
NKTR:
-$121.05M
PGY:
$180.28M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NKTR vs. PGY — Risk / Return Rank
NKTR
PGY
NKTR vs. PGY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nektar Therapeutics (NKTR) and Pagaya Technologies Ltd. (PGY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NKTR | PGY | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.12 | -0.11 | +2.23 |
Sortino ratioReturn per unit of downside risk | 5.22 | 0.41 | +4.81 |
Omega ratioGain probability vs. loss probability | 1.59 | 1.05 | +0.54 |
Calmar ratioReturn relative to maximum drawdown | 9.43 | -0.09 | +9.52 |
Martin ratioReturn relative to average drawdown | 21.73 | -0.15 | +21.88 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NKTR | PGY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.12 | -0.11 | +2.23 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.22 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.13 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.00 | -0.23 | +0.23 |
Drawdowns
NKTR vs. PGY - Drawdown Comparison
The maximum NKTR drawdown since its inception was -99.61%, roughly equal to the maximum PGY drawdown of -98.09%. Use the drawdown chart below to compare losses from any high point for NKTR and PGY.
Loading charts...
Drawdown Indicators
| NKTR | PGY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.61% | -98.09% | -1.52% |
Max Drawdown (1Y)Largest decline over 1 year | -46.54% | -75.71% | +29.17% |
Max Drawdown (3Y)Largest decline over 3 years | -73.20% | -75.71% | +2.51% |
Max Drawdown (5Y)Largest decline over 5 years | -97.76% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -99.61% | — | — |
Current DrawdownCurrent decline from peak | -96.40% | -95.75% | -0.65% |
Average DrawdownAverage peak-to-trough decline | -68.31% | -91.98% | +23.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.20% | 48.07% | -27.87% |
Volatility
NKTR vs. PGY - Volatility Comparison
The current volatility for Nektar Therapeutics (NKTR) is 10.93%, while Pagaya Technologies Ltd. (PGY) has a volatility of 18.02%. This indicates that NKTR experiences smaller price fluctuations and is considered to be less risky than PGY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NKTR | PGY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.93% | 18.02% | -7.09% |
Volatility (6M)Calculated over the trailing 6-month period | 64.10% | 54.35% | +9.75% |
Volatility (1Y)Calculated over the trailing 1-year period | 185.99% | 78.62% | +107.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 121.81% | 144.85% | -23.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 97.16% | 144.85% | -47.69% |
Dividends
NKTR vs. PGY - Dividend Comparison
Neither NKTR nor PGY has paid dividends to shareholders.
Financials
NKTR vs. PGY - Financials Comparison
This section allows you to compare key financial metrics between Nektar Therapeutics and Pagaya Technologies Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NKTR and PGY have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PGY has higher volatility (18.02%) compared to NKTR (10.93%). In terms of maximum drawdown, NKTR dropped -99.61% vs PGY's -98.09%.
NKTR currently has the higher Sharpe Ratio (2.12 vs -0.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NKTR and PGY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer